about
Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinomaAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Diagnosis of hepatocellular carcinoma.Susceptibility-weighted imaging for the noncontrast evaluation of hepatocellular carcinoma: a prospective study with histopathologic correlation.Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolizationHepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRIUltrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre studyThe effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: gelfoam versus polyvinyl alcohol.Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinomaCharacteristics of common solid liver lesions and recommendations for diagnostic workup.TACE versus TAE as therapy for hepatocellular carcinoma.The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinomaTransarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients.Anatomic liver resection of right paramedian sector: ventral and dorsal resection.Survival Benefits of Small Anatomical Resection of the Liver for Patients with Hepatocellular Carcinoma and Impaired Liver Function, Based on New-Era Imaging Studies.Hepatitis C viral load predicts tumor recurrence after curative resection of hepatocellular carcinoma regardless of the genotype of hepatitis C virus.Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats.Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Inferior Right Hepatic Vein: A Useful Anatomic Variation for Isolated Resection of Segment VIII.The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.Portal vein territory identification using indocyanine green fluorescence imaging: Technical details and short-term outcomes.Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma.Resection of segment VIII for hepatocellular carcinoma.FIB-4 Index is a Predictor of Background Liver Fibrosis and Long-Term Outcomes After Curative Resection of Hepatocellular Carcinoma.
P2860
Q24202070-85C6C177-0BB2-4DC0-B135-51F60A81E93DQ30479629-724995AC-2182-47BE-A1E7-0B3506B7946AQ30490554-81B9E02E-F46A-44D5-89E5-8E37B4B84451Q33690177-3BAF2476-246F-4B27-B4D2-292913E34BD8Q33748658-9DDEF739-F8D0-4240-A887-A793188022A9Q33920350-C4935B6A-FE71-4AD8-A84A-8856D32057C3Q34065098-95B7D039-E734-46C5-8C06-9AB238086CC2Q34089545-5D409B69-AFE1-4460-B47E-FE6879DA7292Q35596794-EAF39091-B052-475C-A7CE-FBDF92E6C151Q35720583-09767E51-B4B7-4B6A-A7E5-197CE12BFD25Q36498474-9239011C-BC92-4F22-938F-F45B5D8E46A0Q37262038-F62D07C8-C73C-43CA-A5F7-6C687555AD02Q37300023-12598D35-95F8-4DFC-A6C0-6B06AED5C3A7Q37590135-05AC6C04-0C6A-415C-839C-29D0DCEBA384Q37718937-5C986D6B-35E9-4F50-A7D6-1E1C84E25048Q38424581-FFD2DF54-6F86-4AF4-83A2-7E6B0781F2D2Q39667561-386C8E98-3AE3-4B47-BC60-3535C91D9A13Q40706056-4A9A3354-938A-464B-A4FA-0139F5118982Q40759705-4E52AFAE-81A3-4A05-B881-D5F2A079445EQ41942547-CA90D86A-FDCA-4863-85D8-DD3E3DB27306Q41962614-99DBEB0B-893F-49C2-848B-E7B047FD729CQ42580965-04840E0C-612B-4E86-901E-7C03CD438A27Q44738268-9020E443-07F3-4A81-AB9E-A326981BFE82Q47325220-4C7A7680-6958-4594-91F4-B23F15A73299Q47693164-302CADC4-C80D-43A6-B438-6D798E9520ADQ50495279-00CA9CEE-95CB-42E7-9DED-16107515D2EDQ53791321-CA8C7299-E556-4EB5-8BFD-0FBCF92691F4
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Pathologic characteristics of hepatocellular carcinoma.
@en
Pathologic characteristics of hepatocellular carcinoma.
@nl
type
label
Pathologic characteristics of hepatocellular carcinoma.
@en
Pathologic characteristics of hepatocellular carcinoma.
@nl
prefLabel
Pathologic characteristics of hepatocellular carcinoma.
@en
Pathologic characteristics of hepatocellular carcinoma.
@nl
P356
P1476
Pathologic characteristics of hepatocellular carcinoma.
@en
P2093
P304
P356
10.1055/S-2008-1040608
P577
1986-08-01T00:00:00Z